Home › Sovrappeso › North Carolina › Wilmington
Studi clinici su Sovrappeso a Wilmington, NC
11 studi su Sovrappeso cercano partecipanti presso sedi a Wilmington e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
In reclutamentoFase 2
- Accellacare - Tradd Court - Wilmington /ID# 282200, Wilmington
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
In reclutamentoFase 2
- TMA Headlands, Wilmington
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
In reclutamentoFase 3
- Accellacare and KDCILM, LLC, Wilmington
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
In reclutamentoFase 3
- Trial Management Associates - Wilmington - Floral Parkway, Wilmington
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
In reclutamentoFase 3
- Accellacare - Wilmington, Wilmington
- Jeffrey Coleman, OD, Wilmington
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
In reclutamentoFase 3
- Trial Management Associates - Wilmington - Floral Parkway, Wilmington
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
In reclutamentoFase 3
- Accellacare - Wilmington - 1917 Tradd Court, Wilmington
A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
In reclutamentoFase 3
- KDCILM, LLC & Accellacare US, Inc., Wilmington
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
In reclutamentoFase 3
- Accellacare Research of Wilmington, Wilmington
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
In reclutamentoFase 3
- ACCOMPLISH-1 Research Site, Wilmington
Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
In reclutamentoFase 1
- Accellacare, Wilmington
Studi su Sovrappeso in altre città
- San Antonio, TX34 studi
- Houston, TX33 studi
- Chicago, IL28 studi
- Orlando, FL27 studi
- Las Vegas, NV23 studi
- Miami, FL23 studi
- Atlanta, GA20 studi
- Dallas, TX20 studi
- New York City, NY19 studi
- Jacksonville, FL19 studi
- Washington, DC19 studi
- Austin, TX18 studi
Altri studi a Wilmington
- Obesità15 studi
- Diabete di tipo 28 studi
- Insufficienza cardiaca6 studi
- Colite ulcerosa4 studi
- Pressione alta3 studi
- Malattie cardiovascolari3 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.